The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

被引：0
|
作者：
Bushell, A. [1 ]
van der Net, J. [1 ,2 ]
Game, D.
Hilton, R. [3 ]
Thirkell, S. [4 ]
Friend, P. [2 ]
Geissler, E. [5 ]
Wood, K. [1 ]
Harden, P. [2 ]
Lombardi, G. [4 ]
机构：
[1] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford, England
[2] Oxford Transplant Ctr, Oxford, England
[3] Guys Hosp, London, England
[4] Kings Coll London, Guys Hosp, Immunoregulat Lab, London, England
[5] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D311
引用
收藏
页码：798 / 798
页数：1
相关论文
共 50 条
  • [41] Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
    Dudreuilh, Caroline
    Basu, Sumoyee
    Scotta, Cristiano
    Dorling, Anthony
    Lombardi, Giovanna
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [42] Searching for Factors to Improve Regulatory T Cell Therapy in Organ Transplantation
    Cohen, J. L.
    Pilon, C.
    Maury, S.
    Grimbert, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (10) : 2430 - 2431
  • [43] The ONE Study-therapy with regulatory immune cells in kidney transplantation
    von Samson-Himmelstjerna, Friedrich Alexander
    NEPHROLOGE, 2021, 16 (03): : 181 - 182
  • [44] Taking regulatory T-cell therapy one step further
    Sicard, Antoine
    Boardman, Dominic A.
    Levings, Megan K.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2018, 23 (05) : 509 - 515
  • [45] The Significance of Immune Cell Function Testing in Renal Transplantation.
    Whittaker, Vaughn
    Serban, Geo
    Fan, Jianshe
    Cohen, David
    Ratner, Lloyd
    Suciu-Foca, Nicole
    Colovai, Adriana
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 321 - 321
  • [46] THE SAFETY AND TOLERABILITY OF QEL-001, AN AUTOLOGOUS CHIMERIC ANTIGEN RECEPTOR (CAR) T REGULATORY (TREG) CELL THERAPY, IN LIVER TRANSPLANTATION - A SAFETY COHORT IN THE LIBERATE STUDY
    Sanchez-Fueyo, Alberto
    Taylor, Alison
    Saeb-Parsy, Kourosh
    Martinez-Llordella, Marc
    Clerget, Nathalie
    Sharpe, Chris
    Belmonte, Nathalie
    Vernon, Aaron
    Wang-Jairaj, Jie
    Kenefeck, Rupert
    Cooper, Peter
    Wright, Gareth
    Devey, Luke
    HEPATOLOGY, 2024, 80 : S1051 - S1052
  • [47] A prospective, randomized, multicentre study to compare the efficacy and safety of tacrolimus and ciclosporin microemulsion in renal transplantation.
    Margreiter, R
    TRANSPLANTATION, 2000, 69 (08) : S112 - S113
  • [48] Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
    Harden, Paul N.
    Game, David S.
    Sawitzki, Birgit
    van der Net, Jeroen B.
    Hester, Joanna
    Bushell, Andrew
    Issa, Fadi
    Brook, Matthew O.
    Alzhrani, Alaa
    Schlickeiser, Stephan
    Scotta, Cristiano
    Petchey, William
    Streitz, Mathias
    Blancho, Gilles
    Tang, Quizhi
    Markmann, James
    Lechler, Robert I.
    Roberts, Ian S. D.
    Friend, Peter J.
    Hilton, Rachel
    Geissler, Edward K.
    Wood, Kathryn J.
    Lombardi, Giovanna
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (04) : 1603 - 1611
  • [49] Monitoring of Activated T Cell Is Important for Patients with High BK Viral Load in Renal Transplantation.
    Yin, Wen-Yao
    Lai, Ning-Sheng
    Lu, Ming-Chi
    Lin, Teng-Yi
    Lee, Ming-Che
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 276 - 276
  • [50] FK506 as primary immunosuppressive therapy in renal transplantation.
    Preston, R
    Ball, S
    Cairns, T
    Hakim, N
    Palmer, A
    Papalois, V
    Taube, D
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2093 - 2093
12345